Aram Lyu

460 total citations
10 papers, 278 citations indexed

About

Aram Lyu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Aram Lyu has authored 10 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Aram Lyu's work include Cancer Immunotherapy and Biomarkers (3 papers), Acute Lymphoblastic Leukemia research (2 papers) and Immunotherapy and Immune Responses (2 papers). Aram Lyu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Acute Lymphoblastic Leukemia research (2 papers) and Immunotherapy and Immune Responses (2 papers). Aram Lyu collaborates with scholars based in United States, South Korea and Spain. Aram Lyu's co-authors include Sung Chul Bahn, Hye Seung Jung, Ji Hoon Ahn, Lauren I. R. Ehrlich, Todd Triplett, Seo Hee Nam, R. Dayne Mayfield, Matthew Clark, Lawrence Fong and Richard A. Miller and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Aram Lyu

9 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aram Lyu United States	6	153	117	50	35	29	10	278
Anna P. Petrashen United States	4	237 1.5×	92 0.8×	61 1.2×	24 0.7×	8 0.3×	6	394
Timothy Morello United States	5	312 2.0×	101 0.9×	33 0.7×	65 1.9×	7 0.2×	8	476
Adam Diehl United States	7	330 2.2×	130 1.1×	30 0.6×	41 1.2×	8 0.3×	10	458
Jhih‐Rong Lin United States	9	230 1.5×	26 0.2×	25 0.5×	24 0.7×	8 0.3×	13	329
Yujie Qu China	11	214 1.4×	58 0.5×	67 1.3×	34 1.0×	9 0.3×	16	384
Neale Harrison United Kingdom	10	117 0.8×	18 0.2×	34 0.7×	14 0.4×	8 0.3×	16	226
Minh Thiet Vu Vietnam	7	303 2.0×	159 1.4×	21 0.4×	11 0.3×	9 0.3×	21	423
Tim Lohoff United Kingdom	6	339 2.2×	48 0.4×	36 0.7×	18 0.5×	7 0.2×	10	390
Silje Zandstra Krokeide Norway	8	267 1.7×	16 0.1×	34 0.7×	48 1.4×	14 0.5×	12	334
Yifei Gao China	8	519 3.4×	109 0.9×	36 0.7×	16 0.5×	3 0.1×	13	633

Countries citing papers authored by Aram Lyu

Since Specialization

Citations

This map shows the geographic impact of Aram Lyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aram Lyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aram Lyu more than expected).

Fields of papers citing papers by Aram Lyu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aram Lyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aram Lyu. The network helps show where Aram Lyu may publish in the future.

Co-authorship network of co-authors of Aram Lyu

This figure shows the co-authorship network connecting the top 25 collaborators of Aram Lyu. A scholar is included among the top collaborators of Aram Lyu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aram Lyu. Aram Lyu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Arias-Badia, Marcel, Peixi Chen, Aram Lyu, et al.. (2025). Sequential JAK inhibition enhances antitumor immunity after combined anti–PD-1 and anti-CTLA4. JCI Insight. 10(7). 2 indexed citations

2.

Wen, Ru, Gerald E. Marti, Neeladrisingha Das, et al.. (2025). Abstract 4325: FXYD5 plays diverse roles in immune evasion and tumor progression in prostate cancer. Cancer Research. 85(8_Supplement_1). 4325–4325.

3.

Lyu, Aram, et al.. (2024). Cells and signals of the leukemic microenvironment that support progression of T-cell acute lymphoblastic leukemia (T-ALL). Experimental & Molecular Medicine. 56(11). 2337–2347. 5 indexed citations

4.

Lyu, Aram, Matthew Clark, Averey Lea, et al.. (2024). Evolution of myeloid-mediated immunotherapy resistance in prostate cancer. Nature. 637(8048). 1207–1217. 44 indexed citations

5.

Stark, Jessica C., G. Edward Marti, Zenghua Fan, et al.. (2024). Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancer. Journal of Clinical Investigation. 134(24). 10 indexed citations

6.

Lyu, Aram, Seo Hee Nam, Zicheng Hu, et al.. (2023). Integrin signaling is critical for myeloid-mediated support of T-cell acute lymphoblastic leukemia. Nature Communications. 14(1). 6270–6270. 6 indexed citations

7.

Lyu, Aram, et al.. (2023). 548 Evolution of myeloid-mediated mechanisms of immunotherapy resistance at single-cell resolution with human prostate cancer progression. SHILAP Revista de lepidopterología. A622–A622. 1 indexed citations

8.

Lyu, Aram, Todd Triplett, Seo Hee Nam, et al.. (2020). Tumor-associated myeloid cells provide critical support for T-ALL. Blood. 136(16). 1837–1850. 17 indexed citations

9.

Warden, Anna S., Todd Triplett, Aram Lyu, et al.. (2020). Microglia depletion and alcohol: Transcriptome and behavioral profiles. Addiction Biology. 26(2). e12889–e12889. 31 indexed citations

10.

Bahn, Sung Chul, et al.. (2010). Identification and Testing of Superior Reference Genes for a Starting Pool of Transcript Normalization in Arabidopsis. Plant and Cell Physiology. 51(10). 1694–1706. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact